Sinopharm
1099.HK
#1895
Rank
โ‚น720.04 B
Marketcap
โ‚น230.74
Share price
2.90%
Change (1 day)
10.37%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : โ‚น3.138 Trillion

According to Sinopharm's latest financial reports the company's total liabilities are โ‚น3.138 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sinopharm - Total liabilities on balance sheet (from 2008 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น3.051 T10.81%
2021-12-31โ‚น2.753 T10.98%
2020-12-31โ‚น2.481 T25.98%
2019-12-31โ‚น1.969 T15.66%
2018-12-31โ‚น1.702 T30.71%
2017-12-31โ‚น1.302 T17.63%
2016-12-31โ‚น1.107 T9.61%
2015-12-31โ‚น1.010 T6.88%
2014-12-31โ‚น945.41 B20.52%
2013-12-31โ‚น784.44 B53.54%
2012-12-31โ‚น510.91 B28.5%
2011-12-31โ‚น397.61 B114.96%
2010-12-31โ‚น184.97 B46.21%
2009-12-31โ‚น126.51 B41.08%
2008-12-31โ‚น89.67 B42.84%
2007-12-31โ‚น62.78 B22.95%
2006-12-31โ‚น51.06 B